fentanyl has been researched along with Cancer of Nasopharynx in 4 studies
Fentanyl: A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078)
fentanyl : A monocarboxylic acid amide resulting from the formal condensation of the aryl amino group of N-phenyl-1-(2-phenylethyl)piperidin-4-amine with propanoic acid.
Excerpt | Relevance | Reference |
---|---|---|
"This study evaluated the efficacy, safety, and quality of life (QoL) measure of transdermal fentanyl (TDF) for moderate-to-severe pain due to oral mucositis caused by chemoradiotherapy in patients with advanced nasopharyngeal carcinoma (NPC)." | 7.80 | Transdermal fentanyl for pain due to chemoradiotherapy-induced oral mucositis in nasopharyngeal cancer patients: evaluating efficacy, safety, and improvement in quality of life. ( Feng, HX; Guo, SP; He, ZY; Li, FY; Sun, JY; Wu, SG; Wu, YJ; Zhou, J, 2014) |
"This study evaluated the efficacy, safety, and quality of life (QoL) measure of transdermal fentanyl (TDF) for moderate-to-severe pain due to oral mucositis caused by chemoradiotherapy in patients with advanced nasopharyngeal carcinoma (NPC)." | 3.80 | Transdermal fentanyl for pain due to chemoradiotherapy-induced oral mucositis in nasopharyngeal cancer patients: evaluating efficacy, safety, and improvement in quality of life. ( Feng, HX; Guo, SP; He, ZY; Li, FY; Sun, JY; Wu, SG; Wu, YJ; Zhou, J, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guo, SP | 1 |
Wu, SG | 1 |
Zhou, J | 1 |
Feng, HX | 1 |
Li, FY | 1 |
Wu, YJ | 1 |
Sun, JY | 1 |
He, ZY | 1 |
Granata, R | 1 |
Bossi, P | 1 |
Bertulli, R | 1 |
Saita, L | 1 |
Ezri, T | 1 |
Roth, Y | 1 |
Geva, D | 1 |
Konichezky, S | 1 |
Marshak, G | 1 |
Halperin, D | 1 |
Celiker, V | 1 |
Basgul, E | 1 |
Karagoz, AH | 1 |
Dal, D | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Comparison of Controlled-release Oxycodone to Control Chemoradiotherapy-induced Moderate or Severe Oral Mucositis Pain in Nasopharyngeal Carcinoma Patients[NCT03045484] | 70 participants (Anticipated) | Interventional | 2016-05-31 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
4 other studies available for fentanyl and Cancer of Nasopharynx
Article | Year |
---|---|
Transdermal fentanyl for pain due to chemoradiotherapy-induced oral mucositis in nasopharyngeal cancer patients: evaluating efficacy, safety, and improvement in quality of life.
Topics: Administration, Cutaneous; Adult; Carcinoma; Chemoradiotherapy; Female; Fentanyl; Humans; Male; Midd | 2014 |
Rapid-onset opioids for the treatment of breakthrough cancer pain: two cases of drug abuse.
Topics: Analgesics, Opioid; Breakthrough Pain; Chemoradiotherapy; Coma; Fentanyl; Gastrointestinal Stromal T | 2014 |
Anesthetic management of juvenile nasopharyngeal angiofibroma resection.
Topics: Adjuvants, Anesthesia; Adolescent; Adult; Angiofibroma; Blood Coagulation; Blood Pressure; Blood Vol | 2003 |
Anesthesia in a patient with nasopharyngeal angiofibroma and hemophilia A.
Topics: Adjuvants, Anesthesia; Adolescent; Anesthesia; Anesthetics, Inhalation; Anesthetics, Intravenous; An | 2004 |